JPS6310721A - 制癌剤 - Google Patents

制癌剤

Info

Publication number
JPS6310721A
JPS6310721A JP62065350A JP6535087A JPS6310721A JP S6310721 A JPS6310721 A JP S6310721A JP 62065350 A JP62065350 A JP 62065350A JP 6535087 A JP6535087 A JP 6535087A JP S6310721 A JPS6310721 A JP S6310721A
Authority
JP
Japan
Prior art keywords
alkyl group
compound
lower alkyl
anticancer agent
agent according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP62065350A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6323173B2 (en:Method
Inventor
Setsuo Takeuchi
節男 竹内
Mutsuyuki Kochi
東風　睦之
Akira Kawarada
川原田　璋
Shinichiro Esumi
江角　新一郎
Kazuya Sasaki
和也 佐々木
Shozo Kawabata
河端　昭三
Tsuneo Saida
斉田　常雄
Yukio Inoue
行雄 井上
Tadasu Yamamoto
山本　質
Takaharu Sekine
関根　敬治
Koji Amamiya
雨宮　功治
Katsumasa Saga
嵯峨　克昌
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kaken Pharmaceutical Co Ltd
RIKEN
Original Assignee
Kaken Pharmaceutical Co Ltd
RIKEN
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kaken Pharmaceutical Co Ltd, RIKEN filed Critical Kaken Pharmaceutical Co Ltd
Priority to JP62065350A priority Critical patent/JPS6310721A/ja
Publication of JPS6310721A publication Critical patent/JPS6310721A/ja
Publication of JPS6323173B2 publication Critical patent/JPS6323173B2/ja
Granted legal-status Critical Current

Links

Landscapes

  • Pyridine Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
JP62065350A 1987-03-19 1987-03-19 制癌剤 Granted JPS6310721A (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP62065350A JPS6310721A (ja) 1987-03-19 1987-03-19 制癌剤

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP62065350A JPS6310721A (ja) 1987-03-19 1987-03-19 制癌剤

Publications (2)

Publication Number Publication Date
JPS6310721A true JPS6310721A (ja) 1988-01-18
JPS6323173B2 JPS6323173B2 (en:Method) 1988-05-16

Family

ID=13284417

Family Applications (1)

Application Number Title Priority Date Filing Date
JP62065350A Granted JPS6310721A (ja) 1987-03-19 1987-03-19 制癌剤

Country Status (1)

Country Link
JP (1) JPS6310721A (en:Method)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106831485A (zh) * 2017-03-29 2017-06-13 齐鲁工业大学 二（4‑甲氧基苯亚甲基）丁烷‑1,4‑二胺的制备和用途

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN106831485A (zh) * 2017-03-29 2017-06-13 齐鲁工业大学 二（4‑甲氧基苯亚甲基）丁烷‑1,4‑二胺的制备和用途

Also Published As

Publication number Publication date
JPS6323173B2 (en:Method) 1988-05-16

Similar Documents

Publication Publication Date Title
BE1015217A5 (en:Method)
JPH0367045B2 (en:Method)
CN101429201A (zh) 柠檬酸小檗胺盐及制备方法和应用
US8344017B2 (en) Anti-hepatitis C virus agents and anti-HIV agents
JPS639493B2 (en:Method)
JPS6352012B2 (en:Method)
JPS6310721A (ja) 制癌剤
JPS6334124B2 (en:Method)
JPS6261568B2 (en:Method)
JPS6334123B2 (en:Method)
JPS63264409A (ja) 制癌剤
JPS63264411A (ja) 制癌剤
JPS6352011B2 (en:Method)
JPS6310685B2 (en:Method)
JPS6334125B2 (en:Method)
JPS6344725B2 (en:Method)
JPS6344126B2 (en:Method)
US4882314A (en) A composition and method of treating selected malignant conditions
JPS6334126B2 (en:Method)
JPS639490B2 (en:Method)
JPS638086B2 (en:Method)
JPS6334844B2 (en:Method)
JPS638085B2 (en:Method)
JPS6344127B2 (en:Method)
JPS638924B2 (en:Method)